APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Phosphoinositide 3-Kinase Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Phosphoinositide 3-Kinase Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174025540330 December 2025187 pages

Choose your research edition.

Industry ResearchPhosphoinositide 3-Kinase Inhibitor Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Phosphoinositide 3-Kinase Inhibitor Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Phosphoinositide 3-Kinase Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phosphoinositide 3-Kinase Inhibitor Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Phosphoinositide 3-Kinase Inhibitor Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Phosphoinositide 3-Kinase Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Phosphoinositide 3-Kinase Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phosphoinositide 3-Kinase Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phosphoinositide 3-Kinase Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Phosphoinositide 3-Kinase Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phosphoinositide 3-Kinase Inhibitor include Gilead Sciences Inc., Secura Bio, Inc., TG Therapeutics Inc., Bayer AG and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Phosphoinositide 3-Kinase Inhibitor market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phosphoinositide 3-Kinase Inhibitor and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phosphoinositide 3-Kinase Inhibitor revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Phosphoinositide 3-Kinase Inhibitor market size, projected growth trends, production technologies, key applications, and end-use industries.

Phosphoinositide 3-Kinase Inhibitor Segment by Company

Gilead Sciences Inc.

Secura Bio, Inc.

TG Therapeutics Inc.

Bayer AG

Novartis AG

Phosphoinositide 3-Kinase Inhibitor Segment by Type

Dual PI3K/mTOR inhibitors

Pan-PI3K Inhibitors

Other

Phosphoinositide 3-Kinase Inhibitor Segment by Application

FL - Follicular Iymphoma

CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma

Other Indications

Phosphoinositide 3-Kinase Inhibitor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphoinositide 3-Kinase Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phosphoinositide 3-Kinase Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphoinositide 3-Kinase Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Phosphoinositide 3-Kinase Inhibitor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phosphoinositide 3-Kinase Inhibitor industry.

Chapter 3: Detailed analysis of Phosphoinositide 3-Kinase Inhibitor companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phosphoinositide 3-Kinase Inhibitorrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Dual PI3K/mTOR inhibitors Table 3. Key Players of Pan-PI3K Inhibitors Table 4. Key Players of Other Table 4. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of FL - Follicular Iymphoma Table 6. Key Players of CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma Table 7. Key Players of Other Indications Table 8. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region (2021-2026) Table 11. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region (2027-2032) Table 13. Phosphoinositide 3-Kinase Inhibitor Industry Trends Table 14. Phosphoinositide 3-Kinase Inhibitor Industry Drivers Table 15. Phosphoinositide 3-Kinase Inhibitor Industry Opportunities and Challenges Table 16. Phosphoinositide 3-Kinase Inhibitor Industry Restraints Table 17. Global Phosphoinositide 3-Kinase Inhibitor Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Company (2021-2026) Table 19. Global Phosphoinositide 3-Kinase Inhibitor Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Phosphoinositide 3-Kinase Inhibitor Key Company Head Office and Area Served Table 21. Global Phosphoinositide 3-Kinase Inhibitor Company, Product Type & Application Table 22. Global Phosphoinositide 3-Kinase Inhibitor Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Phosphoinositide 3-Kinase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Type (2021-2026) Table 29. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Type (2027-2032) Table 30. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Application (2021-2026) Table 34. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Application (2027-2032) Table 35. Gilead Sciences Inc. Company Information Table 36. Gilead Sciences Inc. Business Overview Table 37. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Product Portfolio Table 39. Gilead Sciences Inc. Recent Development Table 40. Secura Bio, Inc. Company Information Table 41. Secura Bio, Inc. Business Overview Table 42. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Product Portfolio Table 44. Secura Bio, Inc. Recent Development Table 45. TG Therapeutics Inc. Company Information Table 46. TG Therapeutics Inc. Business Overview Table 47. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Product Portfolio Table 49. TG Therapeutics Inc. Recent Development Table 50. Bayer AG Company Information Table 51. Bayer AG Business Overview Table 52. Bayer AG Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bayer AG Phosphoinositide 3-Kinase Inhibitor Product Portfolio Table 54. Bayer AG Recent Development Table 55. Novartis AG Company Information Table 56. Novartis AG Business Overview Table 57. Novartis AG Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novartis AG Phosphoinositide 3-Kinase Inhibitor Product Portfolio Table 59. Novartis AG Recent Development Table 60. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 61. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 62. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 63. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 64. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 65. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026) Table 66. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032) Table 67. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 68. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 69. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 70. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 71. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026) Table 73. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032) Table 74. China Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 75. China Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 76. China Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 77. China Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 78. Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 79. Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 80. Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 81. Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026) Table 84. Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032) Table 85. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 86. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 87. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 88. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 89. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026) Table 91. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032) Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Phosphoinositide 3-Kinase Inhibitor Product Image Figure 2. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Type: 2025 VS 2032 Figure 4. Dual PI3K/mTOR inhibitors Image Figure 5. Pan-PI3K Inhibitors Image Figure 6. Other Image Figure 7. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Application: 2025 VS 2032 Figure 9. FL - Follicular Iymphoma Image Figure 10. CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma Image Figure 11. Other Indications Image Figure 12. Global Phosphoinositide 3-Kinase Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 14. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Phosphoinositide 3-Kinase Inhibitor Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Type (2021-2032) Figure 21. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Application (2021-2032) Figure 23. North America Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 24. North America Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032) Figure 25. North America Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032) Figure 26. North America Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032) Figure 27. United States Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 28. Canada Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 30. Europe Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 31. Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032) Figure 32. Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032) Figure 33. Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032) Figure 34. Germany Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 35. France Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 37. Italy Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 38. Russia Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 40. China Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 41. China Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032) Figure 42. China Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032) Figure 43. Asia Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 44. Asia Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032) Figure 45. Asia Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032) Figure 46. Asia Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032) Figure 47. Japan Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 51. India Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 52. Australia Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032) Figure 57. Brazil Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 62. UAE Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 64. Chile Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Dual PI3K/mTOR inhibitors
  • Pan-PI3K Inhibitors
  • Other
Applications
  • FL - Follicular Iymphoma
  • CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
  • Other Indications
Companies covered
  • Gilead Sciences Inc.
  • Secura Bio, Inc.
  • TG Therapeutics Inc.
  • Bayer AG
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Dual PI3K/mTOR inhibitors
  5. 1.2.3 Pan-PI3K Inhibitors
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 FL - Follicular Iymphoma
  10. 1.3.3 CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
  11. 1.3.4 Other Indications
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Phosphoinositide 3-Kinase Inhibitor Growth Trends by Region
  14. 1.5.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2021-2026)
  16. 1.5.3 Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Phosphoinositide 3-Kinase Inhibitor Market Dynamics
  1. 2.1 Phosphoinositide 3-Kinase Inhibitor Industry Trends
  2. 2.2 Phosphoinositide 3-Kinase Inhibitor Industry Drivers
  3. 2.3 Phosphoinositide 3-Kinase Inhibitor Industry Opportunities and Challenges
  4. 2.4 Phosphoinositide 3-Kinase Inhibitor Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Phosphoinositide 3-Kinase Inhibitor Revenue by Company (2021-2026)
  2. 3.2 Global Phosphoinositide 3-Kinase Inhibitor Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Phosphoinositide 3-Kinase Inhibitor Key Company Head office and Area Served
  4. 3.4 Global Phosphoinositide 3-Kinase Inhibitor Company, Product Type & Application
  5. 3.5 Global Phosphoinositide 3-Kinase Inhibitor Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Phosphoinositide 3-Kinase Inhibitor Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Phosphoinositide 3-Kinase Inhibitor Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Phosphoinositide 3-Kinase Inhibitor Tier 1, Tier 2, and Tier 3
4 Phosphoinositide 3-Kinase Inhibitor Market by Type
  1. 4.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2032)
  3. 4.3 Global Phosphoinositide 3-Kinase Inhibitor Market Size Share by Type (2021-2032)
5 Phosphoinositide 3-Kinase Inhibitor Market by Application
  1. 5.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2032)
  3. 5.3 Global Phosphoinositide 3-Kinase Inhibitor Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Gilead Sciences Inc.
  2. 6.1.1 Gilead Sciences Inc. Company Information
  3. 6.1.2 Gilead Sciences Inc. Business Overview
  4. 6.1.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Product Portfolio
  6. 6.1.5 Gilead Sciences Inc. Recent Developments
  7. 6.2 Secura Bio, Inc.
  8. 6.2.1 Secura Bio, Inc. Company Information
  9. 6.2.2 Secura Bio, Inc. Business Overview
  10. 6.2.3 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Product Portfolio
  12. 6.2.5 Secura Bio, Inc. Recent Developments
  13. 6.3 TG Therapeutics Inc.
  14. 6.3.1 TG Therapeutics Inc. Company Information
  15. 6.3.2 TG Therapeutics Inc. Business Overview
  16. 6.3.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Product Portfolio
  18. 6.3.5 TG Therapeutics Inc. Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bayer AG Phosphoinositide 3-Kinase Inhibitor Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Novartis AG
  26. 6.5.1 Novartis AG Company Information
  27. 6.5.2 Novartis AG Business Overview
  28. 6.5.3 Novartis AG Phosphoinositide 3-Kinase Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis AG Phosphoinositide 3-Kinase Inhibitor Product Portfolio
  30. 6.5.5 Novartis AG Recent Developments
7 North America
  1. 7.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032)
  2. 7.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type
  3. 7.2.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026)
  4. 7.2.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032)
  5. 7.2.3 North America Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032)
  6. 7.3 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application
  7. 7.3.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026)
  8. 7.3.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032)
  9. 7.3.3 North America Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032)
  10. 7.4 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country
  11. 7.4.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026)
  13. 7.4.3 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032)
  14. 7.4.4 North America Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032)
  2. 8.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type
  3. 8.2.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026)
  4. 8.2.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032)
  5. 8.2.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032)
  6. 8.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application
  7. 8.3.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026)
  8. 8.3.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032)
  9. 8.3.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032)
  10. 8.4 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country
  11. 8.4.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026)
  13. 8.4.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032)
  14. 8.4.4 Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032)
  2. 9.2 China Phosphoinositide 3-Kinase Inhibitor Market Size by Type
  3. 9.2.1 China Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026)
  4. 9.2.2 China Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032)
  5. 9.2.3 China Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032)
  6. 9.3 China Phosphoinositide 3-Kinase Inhibitor Market Size by Application
  7. 9.3.1 China Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026)
  8. 9.3.2 China Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032)
  9. 9.3.3 China Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032)
  2. 10.2 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Type
  3. 10.2.1 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026)
  4. 10.2.2 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032)
  5. 10.2.3 Asia Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032)
  6. 10.3 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Application
  7. 10.3.1 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026)
  8. 10.3.2 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032)
  9. 10.3.3 Asia Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032)
  10. 10.4 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Country
  11. 10.4.1 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026)
  13. 10.4.3 Asia Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032)
  14. 10.4.4 Asia Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst